Literature DB >> 16407018

Prevalence and risk factors for female sexual dysfunction in Turkish women.

Ergun Oksuz1, Simten Malhan.   

Abstract

PURPOSE: We assessed the prevalence of and risk factors for FSD using the Turkish version of the FSFI in Turkish women.
MATERIALS AND METHODS: The study consisted of 518 women 18 to 55 years old living in Ankara, who completed the FSFI for the evaluation of FSD. The women were divided into 3 groups according to age, that is 18 to 30 (273), 31 to 45 (192) and 46 to 55 years (53). Demographic characteristics and risk factors were assessed in all women. Findings were compared between women with and without FSD.
RESULTS: According to the FSFI score 48.3% of women reported FSD (FSFI score less than 25). The prevalence of FSD was 41% at ages 18 to 30 years, 53.1% at ages 31 to 45 years and 67.9% at ages 46 to 55 years. FSD was detected as a desire problem in 48.3% of women, an arousal problem in 35.9%, a lubrication problem in 40.9%, an orgasm problem in 42.7%, a satisfaction problem in 45.0% and a pain problem in 42.9%. Risk factors for FSD were age, smoking (OR 2.4, 95% CI 6.8 to 18.1), menopause (OR 1.7, 95% CI 2.7 to 10.2), diet (OR 1.2, 95% CI 1.9 to 5.5) and marital status (OR 0.8, 95% CI 1.5 to 3.2) (each p <0.001).
CONCLUSIONS: Overall 48.3% of women in our study had FSD according to the FSFI. Apart from age, the most important risk factors for FSD were smoking, diet based life-style changes, menopause status and marital status.

Entities:  

Mesh:

Year:  2006        PMID: 16407018     DOI: 10.1016/S0022-5347(05)00149-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  37 in total

1.  Prevalence and correlates of female sexual dysfunction among Turkish pregnant women.

Authors:  Faruk Küçükdurmaz; Erkan Efe; Önder Malkoç; Eyüp Kolus; Akın Soner Amasyalı; Sefa Resim
Journal:  Turk J Urol       Date:  2016-09

2.  Quality of life, depression, and sexual dysfunction in spouses of female patients with fibromyalgia.

Authors:  Ahmet Tutoglu; Ahmet Boyaci; Irfan Koca; Esra Celen; Nurdan Korkmaz
Journal:  Rheumatol Int       Date:  2014-01-09       Impact factor: 2.631

3.  Translation and validation of the Greek version of the female sexual function index questionnaire.

Authors:  A Zachariou; M Filiponi; P S Kirana
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

4.  Assessment of sexual functions in female patients with ankylosing spondylitis compared with healthy controls.

Authors:  Saliha Eroglu Demir; Aylin Rezvani; Seniz Ok
Journal:  Rheumatol Int       Date:  2012-01-05       Impact factor: 2.631

5.  Is There Any Impact of Copper Intrauterine Device on Female Sexual Functioning?

Authors:  Sezen Bozkurt Koseoglu; Ruya Deveer; Melike Nur Akin; Ali Sami Gurbuz; Burcu Kasap; Huri Guvey
Journal:  J Clin Diagn Res       Date:  2016-10-01

6.  What kind of sexual dysfunction is most common among overweight and obese women in reproductive age?

Authors:  S Rabiepoor; H R Khalkhali; E Sadeghi
Journal:  Int J Impot Res       Date:  2016-11-17       Impact factor: 2.896

7.  Female sexual dysfunction: prevalence and risk factors.

Authors:  Molouk Jaafarpour; Ali Khani; Javaher Khajavikhan; Zeinab Suhrabi
Journal:  J Clin Diagn Res       Date:  2013-12-15

8.  The effect of migraine and tension-type headaches on female sexual functions: A prospective, cross-sectional, controlled study.

Authors:  Mustafa Aydın; Alper Bitkin; Lokman İrkılata; Ahmet Yılmaz; Caner Moral; Mustafa Kemal Atilla
Journal:  Turk J Urol       Date:  2018-09-01

9.  Vitamin D3 deficiency is associated with female sexual dysfunction in premenopausal women.

Authors:  Masum Canat; Lütfi Canat; Feyza Yener Öztürk; Hatice Eroğlu; Hasan Anıl Atalay; Yüksel Altuntaş
Journal:  Int Urol Nephrol       Date:  2016-08-13       Impact factor: 2.370

10.  Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients.

Authors:  Erem K Basok; Necmettin Atsu; Murat M Rifaioglu; Gulcin Kantarci; Asif Yildirim; Resit Tokuc
Journal:  Int Urol Nephrol       Date:  2008-10-14       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.